The best GVHD prophylaxis: Or at least progress towards finding it

Area of Science:

• Immunology
• Transplantation Medicine
• Oncology

Background:

• Graft-versus-host disease (GVHD) remains a significant complication following allogeneic hematopoietic cell transplantation (HCT).
• Effective GVHD prophylaxis is crucial for patient survival and successful engraftment.
• Current strategies aim to balance immunosuppression to prevent GVHD while preserving immune function to combat infection and relapse.

Purpose of the Study:

• To review the pathophysiology of GVHD.
• To explore various prophylaxis strategies for GVHD.
• To highlight the importance of sparing regulatory T cells (Tregs) in GVHD prevention.

Main Methods:

• Review of existing literature on GVHD pathophysiology and prophylaxis.
• Analysis of different T cell-targeted interventions.
• Evaluation of strategies involving antigen-presenting cells (APCs) and co-stimulation blockade.
• Consideration of graft manipulation and pharmacologic approaches.

Main Results:

• GVHD prophylaxis can be tailored by understanding its underlying pathophysiology.
• Interventions targeting T cell activation, expansion, and tissue injury are key.
• Strategies that deplete, tolerize, or blunt T cells or APCs have been employed.
• Blocking co-stimulation and broader inflammation suppression are also utilized.

Conclusions:

• Interventions sparing regulatory T cells (Tregs) may prevent GVHD and facilitate controlled allo-responses.
• Sparing Tregs may not compromise the risk of relapse.
• Both graft manipulations and pharmacologic interventions can limit GVHD morbidity.
• These approaches aim to maintain immunocompetence for infection and relapse prevention.